Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05860257 · ClinicalTrials.gov registry record · NA

Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction

A NA study of Suicidal Ideation and Anxiety Depression, sponsored by University of Oregon.

Active
Registry status
NA
Development phase
1,200
Enrollment target
3
Study locations

NCT05860257: Active NA study of Suicidal Ideation and Anxiety Depression, sponsored by University of Oregon.

NCT05860257 is a NA study of Suicidal Ideation and Anxiety Depression that is active but no longer recruiting, run by University of Oregon. The registered enrollment target is 1,200 participants, above the 254-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (372% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05860257, a NA study of Suicidal Ideation and Anxiety Depression, is active but no longer recruiting, sponsored by University of Oregon.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
3
Study locations

Study Summary

Adolescence is a developmental period of significant risk for anxiety, depressive symptoms, and suicidality, and the investigators propose to target key peer-based risk and protective factors using Cooperative Learning (CL). CL is a small-group instructional approach that can enhance peer relations and reduce peer-related risks, as well as promote academic engagement and achievement and reduce racial disparities. CL will be delivered with the aid of technology that automates the design and delivery of CL lessons, promoting rapid implementation, scalability, high fidelity, accessibility, and sustainability.

Primary Outcome

Anxiety (scores zero to 3, higher scores imply worse outcome)

Interventions

  • BEHAVIORAL PeerLearning.net

Study Locations (3)

Arizona

  • Arizona State University - Tempe

Oregon

  • U of Oregon - Eugene

Wisconsin

  • U of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2023-09-01
Est. Completion 2027-06-15
Phase NA
University of Oregon

63 total trials

What the registry record for NCT05860257 still lists

NCT05860257 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 254-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (372% higher).

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which PeerLearning.net is the first listed.

NCT05860257 reports a single indexed study location in Arizona, Oregon, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05860257 about?

NCT05860257 is a clinical study titled "Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction". Adolescence is a developmental period of significant risk for anxiety, depressive symptoms, and suicidality, and the investigators propose to target key peer-based risk and protective factors using Cooperative Learning (CL). CL is a small-group instructional approach that can enhance peer relations ...

What is the current status of trial NCT05860257?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-09-01. Estimated completion is 2027-06-15.

What conditions does trial NCT05860257 study?

This clinical trial studies the following conditions: Suicidal Ideation, Anxiety Depression.

What interventions are being tested in trial NCT05860257?

The interventions under investigation include: PeerLearning.net (BEHAVIORAL).

Who is sponsoring clinical trial NCT05860257?

This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05860257 being conducted?

This trial has 3 study locations across Arizona, Oregon, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05860257's enrollment target sits among peer trials

1,200 4th of 84 higher than 80 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05860257, the US trial registry maintained by the National Library of Medicine. NCT05860257 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.